More than 300 pathogenic mutations in presenilin 1 or 2 (PSEN1/PSEN2) and amyloid precursor protein (APP) genes have been identified in these autosomal dominant, familial AD (FAD) cases, providing a unique, genetically validated model to study AD pathogenesis. This evidence concerns the gene PSEN1 and Alzheimer disease.